Monitoring a Subcutaneous Monitor’s Progress


By: Linda Watts

MiniMed Inc. is petitioning the FDA for clearance to produce and market its continuous subcutaneous glucose sensor. The company hopes for approval in 1998. MiniMed expects to utilize the sensor for a series of products – the first two being a physician diagnostic device and alarm product to warn people with diabetes of dangerously low glucose levels.

MiniMed designed the sensor to be inserted under the skin surface, usually in the abdominal area.

“We are extremely excited about our subcutaneous glucose sensor products. We believe they will be the industry’s first ambulatory continuous sensor systems for monitoring glucose levels for people with diabetes,” says chairman and CEO Alfred E. Mann.



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.